Skip to content

DG Gel Essential Control 2x2x6ml

by Medion Grifols Diagnostics AG

DG Gel Essential Control 2x2x6ml (213288) is a multiple immunohaematology test IVD made by Medion Grifols Diagnostics AG, listed under FDA premarket submission BK180280 and listed in FDA GUDID since 23 Apr 2019 (UDI-DI 07640137341381), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) BK180280

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number07640137341381 UDI-DI Date23 Apr 2019ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k) from GUDID NumberBK180280 Date—StatusActive

Official records

Across registries

2 registries list this device

  • FDA premarket submission BK180280 Active
  • FDA GUDID UDI-DI 07640137341381 listed 23 Apr 2019 Listed

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
DG Gel Essential Control
Generic name
Multiple immunohaematology test IVD, control
Model / Ref / Catalog
2x2x6ml, 213288
Primary DI / UDI-DI
07640137341381
GMDN term
Multiple immunohaematology test IVD, control
GUDID distribution status
In Commercial Distribution

Other devices from Medion Grifols Diagnostics AG

See all devices from Medion Grifols Diagnostics AG →

Properties

  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (12, all answered No)